fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
.
.
gov. andrew cuomo announced a new lyme and other tick-borne disease control plan tuesday to keep the public informed and free of tick-borne diseases.
. 18 hours ago
.